Evelo Biosciences, Inc.

EVLO · OTC
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$17,262$7,622$27,472$47,940
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,674$3,641$2,609$3,633
Total Curr. Assets$18,936$11,263$30,081$51,573
Property Plant & Equip (Net)$894$8,134$10,733$11,710
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$797$1,422$1,156$1,158
Total NC Assets$1,691$9,556$11,889$12,868
Other Assets$0$0$0$0
Total Assets$20,627$20,819$41,970$64,441
Liabilities
Payables$526$3,765$1,514$1,764
Short-Term Debt$33,948$46,605$43,774$0
Tax Payable$0$0$0$0
Deferred Revenue$0$7,500$0$0
Other Curr. Liab.$1,430-$969$3,684$1,618
Total Curr. Liab.$39,761$55,541$57,247$12,395
LT Debt$0$3,876$0$43,614
Deferred Rev, NC$7,500$7,500$7,500$7,500
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$73$7,528$32$659
Total NC Liab.$7,573$11,404$12,111$57,038
Other Liabilities$0$0$0$0
Cap. Leases$0$6,566$6,922$7,524
Total Liabilities$47,334$66,945$69,358$69,433
Equity
Pref Stock$0$0$0$0
Common Stock$19$6$111$111
Retained Earnings-$588,030-$575,666-$554,563-$529,222
AOCI$0$0$0$0
Other Equity$0$529,534$0$0
Total Equity-$26,707-$46,126-$27,388-$4,992
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$20,627$20,819$41,970$64,441
Net Debt$16,686$42,859$16,302-$4,326